FIUME, LUIGI
Dettaglio
FIUME, LUIGI
DIP. DI PATOLOGIA SPERIMENTALE
Pubblicazioni
Risultati 1 - 20 di 30 (tempo di esecuzione: 0.0 secondi).
Titolo | Autore(i) | Anno | Periodico | Editore | Tipo | File | |
---|---|---|---|---|---|---|---|
1 | A conjugate of doxorubicin with lactosaminated albumin enhances the drug concentrations in all the forms of rat hepatocellular carcinomas independently of their differentation grade. | Di Stefano G.; Fiume L.; Baglioni M.; Bolondi L.; Busi C.; Chieco P.; Kratz F.; Manaresi F.; Pari...ali M. | 2006 | LIVER INTERNATIONAL | 1.01 Articolo in rivista | - | |
2 | A novel method for coupling doxorubicin to lactosaminated human albumin by an acid sensitive hydrazone bond: synthesis, characterization and preliminary biological properties of the conjugate. | DI STEFANO G.; LANZA M.; KRATZ F.; MERINA L.; FIUME L. | 2004 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
3 | Albumin-drug conjugates in the treatment of hepatic disorders. | Fiume L;Manerba M;Di Stefano G | 2014 | EXPERT OPINION ON DRUG DELIVERY | 1.01 Articolo in rivista | - | |
4 | Binding of the doxorubicin-lactosaminated human albumin conjugate to HCC cells is mediated by the drug moieties. | Baglioni M.; Fiume L.; Bolondi L.; Farina C.; Kratz F.; Di Stefano G. | 2008 | DIGESTIVE AND LIVER DISEASE | 1.01 Articolo in rivista | - | |
5 | Characterisation of the conjugate of the (6-maleimidocaproyl)hydrazone derivative of doxorubicin with lactosaminated human albumin by 13C NMR spectroscopy. | Boga C.; Fiume L.; Baglioni M.; Bertucci C.; Farina C.; Kratz F.; Manerba M.; Naldi M.; Di Stefan...o G. | 2009 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
6 | Coupling of lactose molecules to the carrier protein hinders the spleen and bone marrow uptake of doxorubicin conjugated with human albumin | Di Stefano G; Fiume L; Baglioni M; Busi C; Chieco P; Kratz F; Mattioli A. | 2007 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
7 | Doxorubicin coupled to lactosaminated albumin inhibits the growth of hepatocellular carcinomas induced in rats by diethylnitrosamine. | FIUME L.; BOLONDI L.; BUSI C.; CHIECO P.; KRATZ F.; LANZA M.; MATTIOLI A.; DI STEFANO G. | 2005 | JOURNAL OF HEPATOLOGY | 1.01 Articolo in rivista | - | |
8 | Doxorubicin coupled to lactosaminated albumin: effect of heterogeneity in drug load on conjugate disposition and hepatocellular carcinoma uptake in rats. | Di Stefano G.; Fiume L.; Baglioni M.; Busi C.; Bolondi L.; Farina C.; Mori F.; Chieco P.; Pariali... M.; Kratz F.; Molin L.; Salmaso S.; Caliceti P. | 2008 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
9 | Doxorubicin coupled to lactosaminated albumin: effects on rats with liver fibrosis and cirrhosis. | Di Stefano G; Fiume L; Domenicali M; Busi C; Chieco P; Kratz F; Lanza M; Mattioli A; Pariali M; B...ernardi M. | 2006 | DIGESTIVE AND LIVER DISEASE | 1.01 Articolo in rivista | - | |
10 | Doxorubicin coupled to lactosaminated albumin: enhanced drug levels in rat hepatocarcinomas. | Di Stefano G.; Busi C.; Chieco P.; Pariali M.; Fiume L. | 2006 | DIGESTIVE AND LIVER DISEASE | 1.01 Articolo in rivista | - | |
11 | Doxorubicin coupled to lactosaminated human albumin: a hepatocellular carcinoma targeted drug. | Fiume L.; Baglioni M.; Bolondi L.; Farina C.; Di Stefano G. | 2008 | DRUG DISCOVERY TODAY | 1.01 Articolo in rivista | - | |
12 | Effect of sorafenib on the energy metabolism of hepatocellular carcinoma cells. | Fiume L.; Manerba M.; Vettraino M.; Di Stefano G. | 2011 | EUROPEAN JOURNAL OF PHARMACOLOGY | 1.01 Articolo in rivista | - | |
13 | Efficacy of doxorubicin coupled to lactosaminated albumin on rat hepatocellular carcinomas evaluated by ultrasound imaging. | Di Stefano G.; Fiume L.; Baglioni M.; Bolondi L.; Chieco P.; Kratz F.; Pariali M.; Rubini G. | 2008 | DIGESTIVE AND LIVER DISEASE | 1.01 Articolo in rivista | - | |
14 | Enhanced uptake of lactosaminated human albumin by rat hepatocarcinomas: implications for an improved chemotherapy of primary liver tumors. | DI STEFANO G.; FIUME L.; BOLONDI L.; LANZA M.; PARIALI M.; CHIECO P. | 2005 | LIVER INTERNATIONAL | 1.01 Articolo in rivista | - | |
15 | Galloflavin (CAS 568-80-9), a novel inhibitor of lactate dehydrogenase. | Manerba M.; Vettraino M.; Fiume L.; Di Stefano G.; Sartini A.; Giacomini E.; Buonfiglio R.; Rober...ti M.; Recanatini M. | 2012 | CHEMMEDCHEM | 1.01 Articolo in rivista | - | |
16 | Galloflavin prevents the binding of lactate dehydrogenase A to single stranded DNA and inhibits RNA synthesis in cultured cells. | Fiume L.; Vettraino M.; Carnicelli D.; Arfilli V.; Di Stefano G.; Brigotti M. | 2013 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1.01 Articolo in rivista | - | |
17 | Galloflavin, a new lactate dehydrogenase inhibitor, induces the death of human breast cancer cells with different glycolytic attitude by affecting distinct signaling pathways. | Farabegoli F.; Vettraino M.; Manerba M.; Fiume L.; Roberti M.; Di Stefano G. | 2012 | EUROPEAN JOURNAL OF PHARMACEUTICAL SCIENCES | 1.01 Articolo in rivista | - | |
18 | Impairment of aerobic glycolysis by inhibitors of lactic dehydrogenase hinders the growth of human hepatocellular carcinoma cell lines. | Fiume L; Manerba M; Vettraino M; Di Stefano G | 2010 | PHARMACOLOGY | 1.01 Articolo in rivista | - | |
19 | The inhibition of lactate dehydrogenase A hinders the transcription of histone 2B gene independently from the block of aerobic glycolysis | Brighenti, Elisa; Carnicelli, Domenica; Brigotti, Maurizio; Fiume, Luigi | 2017 | BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS | 1.01 Articolo in rivista | - | |
20 | Inhibition of lactate dehydrogenase activity as an approach to cancer therapy | Luigi FIUME; Marcella MANERBA; Marina VETTRAINO; Giuseppina DI STEFANO | 2014 | FUTURE MEDICINAL CHEMISTRY | 1.01 Articolo in rivista | - |